SCHEMBL9255067

SCHEMBL9255067

CCOC(=O)CCc1cn(-c2ccc(-c3ccc(C(=N)NC(=O)OCC)cc3)nn2)cn1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 2/20 0.33
RAB9A P51151 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
ALOX5 P09917 1/20 0.32
MAPT P10636 2/20 0.31
USP2 O75604 1/20 0.31
EP300 Q09472 4/20 0.31
MAPK1 P28482 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
NPC1 O15118 3/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31
KLKB1 P03952 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
TSHR P16473 1/20 0.30
NAMPT P43490 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9259482 0.89 PDK1 (0.33) PDK1RAB9ASMN1; SMN2ALOX5MAPT
SCHEMBL9254094 0.87 F2 (0.37) PDK1RAB9ASMN1; SMN2MAPTUSP2
SCHEMBL9250749 0.86 ALOX5 (0.30) PDK1ALOX5
SCHEMBL9257621 0.84 PDK1 (0.36) PDK1
SCHEMBL9255212 0.83 PDK1 (0.33) PDK1RAB9ASMN1; SMN2MAPTNPC1
SCHEMBL9254355 0.82 PDK1 (0.35) PDK1NPC1
SCHEMBL9256865 0.81 MAPT (0.33) PDK1SMN1; SMN2MAPTNPC1HSD17B10
SCHEMBL8863938 0.80 TMPRSS15 (0.36) PDK1RAB9ASMN1; SMN2MAPTNPC1
SCHEMBL9257803 0.80 MAPT (0.35) MAPT
SCHEMBL9254692 0.79 F10 (0.34) PDK1MAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5463071-A Tetrazole derivatives; useful for inhibiting undesirable cell aggregation DR. KARL THOMAE GMBH (DE) 1995-10-31 US disclosed
EP-0525629-A2 5-membered heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-02-03 EP disclosed